Ruiyang He
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ruiyang He has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Amy Cameron
Dana-Farber Cancer Institute Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology Boston, Massachusetts
57 shared publications - Aniket Shetty
Center for Patient-Derived Models, Dana-Farber Cancer Institute, Boston, Massachusetts
57 shared publications - Hyeji Jun
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
57 shared publications - Quang-Dé Nguyen
Dana-Farber Cancer Institute 2 Boston, MA
57 shared publications - Saie Mogre
Pennsylvania State University 1 Department of Veterinary and Biomedical Sciences University Park, PA 16802
57 shared publications - Sarah J. Hill
Dana-Farber Cancer Institute 1 Department of Medical Oncology Boston, Massachusetts
57 shared publications
Latest Publications
- Open Access
- 15 September 2026
- Published by The Company of Biologists in Development
- Vol. 153 (18)
Subepithelial myofibroblasts enhance stem cell regeneration after intestinal epithelial damage
When intestinal stem cells (ISCs) are damaged, other epithelial cells de-differentiate to restore the ISC compartment. Immune, nerve and lymphatic endothelial cells contribute signals that promote this response, but it is unclear whether or how the native mesenchymal niche senses and responds to ISC loss. In homeostasis, trophocytes and smooth muscle beneath intestinal crypts secrete BMP inhibitors (BMPi) and R-spondins to foster ISC self-renewal, whereas sub-epithelial myofibroblasts (SEMFs) concentrated at crypt tops promote differentiation through bone morphogenetic proteins (BMPs). We assessed transcriptional responses in mouse sub-epithelial populations after ablating ISCs with whole-body irradiation and treating Lgr5DTR mice with diphtheria toxin. More than any other cell type, SEMFs modulated expression of genes related to ISC expansion. However, the BMPi gene Smoc1 and non-canonical Wnt signals, both expressed in SEMFs after whole-body irradiation, were dispensable for ISC restoration. Instead, SEMFs appear to support ISC regeneration through factors that are not induced by ISC attrition per se but by local inflammation. These findings reveal unexpectedly limited transcriptional modulation of the native niche after ISC losses and context-dependent signaling functions for SEMFs.
- 15 September 2026
- Published by The Company of Biologists in Development
- Vol. 153 (18)
Open AccessSubepithelial myofibroblasts enhance stem cell regeneration after intestinal epithelial damage
When intestinal stem cells (ISCs) are damaged, other epithelial cells de-differentiate to restore the ISC compartment. Immune, nerve and lymphatic endothelial cells contribute signals that promote this response, but it is unclear whether or how the native mesenchymal niche senses and responds to ISC loss. In homeostasis, trophocytes and smooth muscle beneath intestinal crypts secrete BMP inhibitors (BMPi) and R-spondins to foster ISC self-renewal, whereas sub-epithelial myofibroblasts (SEMFs) concentrated at crypt tops promote differentiation through bone morphogenetic proteins (BMPs). We assessed transcriptional responses in mouse sub-epithelial populations after ablating ISCs with whole-body irradiation and treating Lgr5DTR mice with diphtheria toxin. More than any other cell type, SEMFs modulated expression of genes related to ISC expansion. However, the BMPi gene Smoc1 and non-canonical Wnt signals, both expressed in SEMFs after whole-body irradiation, were dispensable for ISC restoration. Instead, SEMFs appear to support ISC regeneration through factors that are not induced by ISC attrition per se but by local inflammation. These findings reveal unexpectedly limited transcriptional modulation of the native niche after ISC losses and context-dependent signaling functions for SEMFs.
- Open Access
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Figure S4 from Functional Profiling of p53 and RB Cell Cycle Regulatory Proficiency Suggests Mechanism-Driven Molecular Stratification in Endometrial Carcinoma
Figure S4 C B A Figure S4. Gating strategies for CDK4/6 inhibitor cell cycle flow cytometry corresponding to Figures 1G and 1I. Cell or organoid lines were treated with vehicle (DMSO) or 0.25µM of the CDK4/6 inhibitor (CDK4/6i) Abemaciclib for 24 hours. The cell lines were pulsed with bromodeoxyuridine (BrdU) or the organoids were pulsed with 5-Ethynyl-2'-deoxyuridine (EdU). Cells were harvested, fixed, and stained with appropriate antibodies or chemicals as well as propidium iodide (PI) and then analyzed on a flow cytometer. Gating strategies from one replicate of some of the data in Figures 1G and 1I are shown here as described below. A) Shown here is a general gating strategy for one replicate of the DMSO treated HEC1B cell line on the left or the EMCA-A organoid line on the right. In each case, cells were first gated on the side scatter (SSC)/forward scatter (FSC) plot. From cells, singlets representing cells with 2N and 4N DNA content were gated on the PI-Height (H)/PI-Area (A) plot. Singlets were then plotted with PI on the X axis and either BrdU-FITC for cell lines or EdU for organoids on the Y axis. Cells which had a 2N DNA content and were negative for BrdU or EdU were gated as G1 phase. Cells which had a 4N DNA content and were negative for BrdU or EdU were gated as G2/M phase. Cells which were EdU or BrdU positive were gated and quantified as being in S phase. B) BrdU (Y-axis)/PI (X-axis) gating strategies are shown for all cell lines treated with vehicle (top) or CDK4/6i Abemaciclib (bottom) corresponding to Figure 1G. C) EdU (Y-axis)/PI (X-axis) gating strategies are shown for all organoid lines treated with vehicle (top) or CDK4/6i Abemaciclib (bottom) corresponding to Figure 1I. HEC1B DMSO DMSO CDK4/6i (Abemaciclib) EMCA-A UPSC-A CS-A CS-B EMCA-A DMSO EdU-A EdU-A EdU-A
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Functional Profiling of p53 and RB Cell Cycle Regulatory Proficiency Suggests Mechanism-Driven Molecular Stratification in Endometrial Carcinoma
Figure S4 C B A Figure S4. Gating strategies for CDK4/6 inhibitor cell cycle flow cytometry corresponding to Figures 1G and 1I. Cell or organoid lines were treated with vehicle (DMSO) or 0.25µM of the CDK4/6 inhibitor (CDK4/6i) Abemaciclib for 24 hours. The cell lines were pulsed with bromodeoxyuridine (BrdU) or the organoids were pulsed with 5-Ethynyl-2'-deoxyuridine (EdU). Cells were harvested, fixed, and stained with appropriate antibodies or chemicals as well as propidium iodide (PI) and then analyzed on a flow cytometer. Gating strategies from one replicate of some of the data in Figures 1G and 1I are shown here as described below. A) Shown here is a general gating strategy for one replicate of the DMSO treated HEC1B cell line on the left or the EMCA-A organoid line on the right. In each case, cells were first gated on the side scatter (SSC)/forward scatter (FSC) plot. From cells, singlets representing cells with 2N and 4N DNA content were gated on the PI-Height (H)/PI-Area (A) plot. Singlets were then plotted with PI on the X axis and either BrdU-FITC for cell lines or EdU for organoids on the Y axis. Cells which had a 2N DNA content and were negative for BrdU or EdU were gated as G1 phase. Cells which had a 4N DNA content and were negative for BrdU or EdU were gated as G2/M phase. Cells which were EdU or BrdU positive were gated and quantified as being in S phase. B) BrdU (Y-axis)/PI (X-axis) gating strategies are shown for all cell lines treated with vehicle (top) or CDK4/6i Abemaciclib (bottom) corresponding to Figure 1G. C) EdU (Y-axis)/PI (X-axis) gating strategies are shown for all organoid lines treated with vehicle (top) or CDK4/6i Abemaciclib (bottom) corresponding to Figure 1I. HEC1B DMSO DMSO CDK4/6i (Abemaciclib) EMCA-A UPSC-A CS-A CS-B EMCA-A DMSO EdU-A EdU-A EdU-A